Vimarsana
Biggest News Aggregation in the World

Page 4 - Drug Admin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Drug Admin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Drug Admin Today - Breaking & Trending Today

Health Plan Coverage of Abortion and Related Services | Practical Law The Journal - Vimarsana News

Health Plan Coverage of Abortion and Related Services | Practical Law The Journal

Employer-sponsored health plan coverage of surgical and medication abortion and related services, including travel benefits, has been the subject of extensive litigation since the US Supreme Court’s 2022 decision in Dobbs v. Jackson Women’s Health Organization.

What's Next For Mifepristone? - Healthcare - Vimarsana News

What's Next For Mifepristone? - Healthcare

Medication abortions using mifepristone and misoprostol now account for more than half of all abortions performed in the United States today...

Source: mondaq.com
Managing Ransomware Risk in Health Systems | Maynard Nexsen - Vimarsana News

Managing Ransomware Risk in Health Systems | Maynard Nexsen

Ransomware is the “fastest growing malware threat.” In 2022, attacks in health care increased by 328%, a study found. Another recent study reports that from 2016 to 2021, the “annual...

Client Alert: What's Next for Mifepristone? | Jenner & Block - Vimarsana News

Client Alert: What's Next for Mifepristone? | Jenner & Block

Medication abortions using mifepristone and misoprostol now account for more than half of all abortions performed in the United States today. In the post-Dobbs era, medication abortion...

Potential Nitrosamine Contamination Results in Another Voluntary Pharmaceutical Recall | Nelson Mullins Riley & Scarborough LLP - Vimarsana News

Potential Nitrosamine Contamination Results in Another Voluntary Pharmaceutical Recall | Nelson Mullins Riley & Scarborough LLP

On March 22, 2023, at the request of the U.S. Food and Drug Administration (“FDA”), Ascend Laboratories LLC. (“Ascend”) issued a voluntary nationwide recall of certain lots of...